Seegene enters the U.S. diagnostic market in collaboration with Thermo Fisher Scientific
PR Newswire 2017.05.22 Seoul, Korea, 2017/05/22 – Seegene Inc. (096530.KQ), the world’s leading developer of multiplex molecular diagnostics technologies and assays, today announced that it has entered into a new strategic collaboration relationship with Thermo Fisher Scientific in which Seegene will file for U.S Food and Drug Administration (FDA) clearance of its AllplexTM diagnostic assay... Read more